AGENT FOR INHIBITING RECURRENCE OF HEMATOLOGICAL MALIGNANCY IN PATIENTS WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION

摘要

A drug to inhibit the recurrence of hematological malignancy and/or a drug to improve the survival rate in patients who have undergone hematopoietic stem cell transplantation to treat a hematological malignancy, the drug having as an active ingredient 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-propane-1,3-diol or a pharmacologically acceptable salt thereof.